Cargando…
Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections. Properties such as T helper cell function, T cell memory, and CD8+ T cell cytotoxicity may play critical roles in optimal a...
Autores principales: | Rapaka, Rekha R., Cross, Alan S., McArthur, Monica A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402546/ https://www.ncbi.nlm.nih.gov/pubmed/34451945 http://dx.doi.org/10.3390/vaccines9080820 |
Ejemplares similares
-
Next Generation Vaccines for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2019) -
Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy
por: Nikitin, Nikolai, et al.
Publicado: (2023) -
Emerging Infectious Diseases
por: McArthur, Donna Behler
Publicado: (2019) -
Advances in Infectious Disease Vaccine Adjuvants
por: Fan, Jingyi, et al.
Publicado: (2022) -
Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)